Clinical Trial Update: Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether adding intracavernosal therapy to sildenafil 100 mg improves erectile dysfunction in men not sufficiently responsive t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Intracavernosal add-on therapy
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED